Clinical trial
The Efficacy and Safety of Dayingpian in The Treatment of Bipolar Disorder
NCT05247593 is registered in ClinicalTrials.gov with Shanghai Mental Health Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Efficacy and Safety of Dayingpian in The Treatment of Bipolar Disorder
- Lead sponsor
- Shanghai Mental Health Center
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- August 1, 2022
- Completion date
- September 30, 2024
- Enrollment
- 308 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.